Effect of adalimumab interventions on general infection among adults: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Effect of adalimumab interventions on general infection among adults: a systematic review and meta-analysis of randomized controlled trials

Published:2021-04-13 Issue:10 Volume:19 Page:1281-1297
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Wang Yen-Chun¹,Feng Yu-Tung²,Lin Yu-Chun¹,Lee Chi-Tai³,Tung Tao-Hsin⁴

Affiliation:

1. Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan

2. Graduate Institute of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Kaohsiung, Taiwan

3. Department of Pharmacy, Kaohsiung Veterans General Hospital. ., Zuoying Dist., Kaohsiung City, Taiwan

4. Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Zhejiang China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2021.1902804

Reference47 articles.

1. Drug Approval Package: HUMIRA (adalimumab) https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/125057_toc.cfm. Accessed: December 8, 2020.

2. “Adalimumab Monograph for Professionals”. Drugs.com. American Society of Health-System Pharmacists. https://www.drugs.com/mtm/adalimumab.html. Accessed: December 8, 2020.

3. Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan

4. Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Safety and efficacy of adalimumab in treating difficult-to-treat rheumatoid arthritis in a human immunodeficiency virus-positive patient, one year follow-up;Frontiers in Immunology;2022-08-03